BE825646A - Composes chimiques pour le traitement de trichomoniasis et de candida albicans, ainsi que procede pour leur obtention - Google Patents
Composes chimiques pour le traitement de trichomoniasis et de candida albicans, ainsi que procede pour leur obtentionInfo
- Publication number
- BE825646A BE825646A BE153451A BE153451A BE825646A BE 825646 A BE825646 A BE 825646A BE 153451 A BE153451 A BE 153451A BE 153451 A BE153451 A BE 153451A BE 825646 A BE825646 A BE 825646A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- treatment
- formula
- obtaining
- candida albicans
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 11
- 238000000034 method Methods 0.000 title claims description 5
- 241000222122 Candida albicans Species 0.000 title claims description 3
- 229940095731 candida albicans Drugs 0.000 title claims description 3
- 238000011282 treatment Methods 0.000 title description 12
- 208000005448 Trichomonas Infections Diseases 0.000 title 1
- 206010044620 Trichomoniasis Diseases 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 3
- 229960000583 acetic acid Drugs 0.000 claims description 2
- 230000001857 anti-mycotic effect Effects 0.000 claims description 2
- 230000000884 anti-protozoa Effects 0.000 claims description 2
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 claims description 2
- 239000012362 glacial acetic acid Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000002543 antimycotic Substances 0.000 claims 1
- 238000001816 cooling Methods 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FUBFWTUFPGFHOJ-UHFFFAOYSA-N 2-nitrofuran Chemical class [O-][N+](=O)C1=CC=CO1 FUBFWTUFPGFHOJ-UHFFFAOYSA-N 0.000 description 1
- -1 3- (Methyl-5-nitro-2-imidazolyl) 2-acetyl-propenoic acid ethyl ester Chemical compound 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000224527 Trichomonas vaginalis Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229940058965 antiprotozoal agent against amoebiasis and other protozoal diseases nitroimidazole derivative Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- GCHKUUOPYMFGEY-UHFFFAOYSA-N ethyl 2-[(1-methyl-5-nitroimidazol-2-yl)methylidene]-3-oxobutanoate Chemical compound CCOC(=O)C(C(C)=O)=CC1=NC=C([N+]([O-])=O)N1C GCHKUUOPYMFGEY-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 150000004957 nitroimidazoles Chemical class 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002963 trichomonacidal effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT4893074 | 1974-03-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE825646A true BE825646A (fr) | 1975-06-16 |
Family
ID=11269068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE153451A BE825646A (fr) | 1974-03-04 | 1975-02-17 | Composes chimiques pour le traitement de trichomoniasis et de candida albicans, ainsi que procede pour leur obtention |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | AT344690B (de) |
| BE (1) | BE825646A (de) |
| HU (1) | HU169770B (de) |
| SU (1) | SU535904A3 (de) |
-
1975
- 1975-02-17 BE BE153451A patent/BE825646A/fr not_active IP Right Cessation
- 1975-03-03 SU SU2111217A patent/SU535904A3/ru active
- 1975-03-04 AT AT167575A patent/AT344690B/de not_active IP Right Cessation
- 1975-03-04 HU HUSA002753 patent/HU169770B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AT344690B (de) | 1978-08-10 |
| HU169770B (de) | 1977-02-28 |
| ATA167575A (de) | 1977-12-15 |
| SU535904A3 (ru) | 1976-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2460919A1 (fr) | Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique | |
| EP0015038A1 (de) | Ein Diphenylhydantoin-Derivat enthaltende pharmazeutische Zusammensetzung, verwendete Derivate und ihre Herstellung | |
| EP0117771B1 (de) | Imino-2-pyrrolidine, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung | |
| EP0109866A1 (de) | Sulfonylharnstoff-Derivate, Verfahren zur Herstellung und pharmazeutische Zusammenstellungen die sie enthalten | |
| EP0349432B1 (de) | Strontiumsalz, Verfahren zu dessen Herstellung und Arzneimittel, die es enthalten | |
| CH447200A (fr) | Procédé de préparation des acides carboxyliques a-substitués | |
| EP0200605A1 (de) | Nitrofuranderivate, ihre Herstellung und ihre Anwendung in der Therapie | |
| BE825646A (fr) | Composes chimiques pour le traitement de trichomoniasis et de candida albicans, ainsi que procede pour leur obtention | |
| FR2600647A1 (fr) | Derives de la glycine | |
| WO1979000231A1 (fr) | Nouveaux derives de la thiazoline et leur application comme medicaments | |
| CH637650A5 (fr) | Procede de preparation d'un acide chromone carboxylique. | |
| CA1128511A (fr) | Derives de 1,3-benzoxazine-2,4-dione, leur preparation et leur application en tant que medicaments | |
| KR850000210B1 (ko) | 옥사졸린의 제조방법 | |
| US3960882A (en) | Chemical compounds for trichomoniasis and candidiosis treatment | |
| FR2708611A1 (fr) | Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant. | |
| EP1007522B1 (de) | 2- 4-[4-(4,5-dichlor-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluorpyrimidin, seine herstellung und therapeutische verwendung | |
| EP0020230A2 (de) | p-Biphenyl-4-methyl-2-butensäuren, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendung | |
| EP0210886B1 (de) | Tertiäre halogenierte Biphenylalkohole die nützlich in der Therapeutik bei der Behandlung von Atheriosklerose sind | |
| EP0022737B1 (de) | Als Arzneimittel verwendbare Iminderivate von 5-Amino-1,3-benzodioxol und ihre Herstellung | |
| EP0288647B1 (de) | Derivate von 5-[2-(1-Pyrrolidinyl)-äthoxy]-p-cymen, Verfahren zu ihrer Herstellung und diese Derivate enthaltende Arzneimittel | |
| FR2581643A1 (fr) | Compositions pharmaceutiques utiles dans le domaine de l'urologie, contenant de l'acetoxy-1 methyl-2 ((piperidino)-2 ethoxy)-4 (methyl-1 ethyl)-5 benzene ou l'un de ses sels | |
| EP0039294B1 (de) | Bis-(substituierte Phenoxyacetate) von N-Alkyl-dialkanolaminen, Verfahren zu ihrer Bereitung, und diese enthaltende pharmazeutische Zusammensetzungen | |
| FR2491471A1 (fr) | Benzoxazolinones substituees, leur preparation et leur application en therapeutique | |
| EP0151052A2 (de) | Aminoäthylimidazole, pharmazeutische Zusammensetzungen die sie enthalten und Verfahren zu ihrer Herstellung | |
| FR2518090A1 (fr) | Ethers d'oximes a-b insatures, leur procede de preparation et leur utilisation comme medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: STABILIMENTO BIOTERAPICO FARMACOLOGICO LA FARMOCH Effective date: 19860228 |